1. Montuschi P. et al. PHARMACOLOGICAL TREATMENT OF
CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ...
Drug Discov Today. 2014.;
19(2):1928-35.
2. Blasi F. et al. COPD AND BRONCHIECTASIS: PHENOTYPE,
ENDOTYPE OR CO-MORBIDITY?
COPD. 2014; 11(6):603-4.
3. Oh YM et al. EMPHYSEMATOUS PHENOTYPE IS AN INDEPENDENT
PREDICTOR FOR FREQUENT EXACERBATION OF COPD
Int J Tuberc Lung Dis. 2014.;
18(12):1407-14.
4. Malhotra R, Olsson H. IMMUNOLOGY, GENETICS AND
MICROBIOTA IN THE COPD PATHOPHYSIOLOGY: ...
Expert Rev Respir Med. 2015.;
9(2):153-9.
5. Vaz Fragoso CA et al. PHENOTYPE OF NORMAL SPIROMETRY IN
AN AGING POPULATION
Am J Respir Crit Care Med. 2015.;
192(7):817-25.
6. Turner AM et al. CLINICALLY RELEVANT SUBGROUPS IN COPD
AND ASTHMA
Eur Respir Rev. 2015.;
24(136):283-98.
7. Green CE et al. PiSZ ALPHA-1 ANTITRYPSIN DEFICIENCY
(AATD): ...
Thorax. 2015.;
70(10):939-45.
8. Byrne AJ et al. PULMONARY MACROPHAGES: KEY PLAYERS IN
THE INNATE DEFENCE OF THE AIRWAYS
Thorax. 2015.;
70(12):1189-96.
Thanks in advance!
Robert Neziroviæ, librarian from General Hospital Zadar, Croatia,
EUROPE
